Immune response to tumor cell

pathway activity — cross-omics
GO:0002418Cross-omicsPROTEIN-MS → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Immune response to tumor cell pathway is significantly associated with the protein abundance of multiple proteins, with the LSCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are HLA-A_S352, HLA-A, and HLA-A_S356, each associated with the pathway in up to 7 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Immune response to tumor cell activity versus HLA-A_S352 in LSCC (Pearson r = 0.81).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LSCCHLA-A_S352 →+2.871+0.420<.001<.00137
UCECHLA-A →+1.100+0.344<.001<.00136
LSCCHLA-A_S356 →+2.621+0.389<.001<.00136
LSCCHLA-A_S359 →+2.300+0.366<.001<.00135
GBMIRF5 →+0.421+0.170<.001<.00135
GBMITGAL →+0.562+0.175<.001<.00135
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0002418 vs HLA-A_S352 — LSCC

Per-sample scatter of Immune response to tumor cell activity vs HLA-A_S352 in LSCC.

Explore this scatter interactively →

Exploration